Thus, recent evidence from a rat model of heart IRI showed that although IRI undoubtedly increased the release of syndecan-1 in the coronary effluent, treatment with S1P before development of ischemia had no visible effect on syndecan-1 release [154]. This evidence concerns the gene SDC1 and ischemia.